Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour

[1] Mieog J(2007)Neoadjuvant chemotherapy for operable breast cancer Br J Surg 94 1189-1200

[2] Van der Hage J(2015)Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy Nat Rev Clin Oncol 12 335-343

[3] Van De Velde C(2011)Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients Eur J Cancer 47 2084-2090

[4] King TA(2012)Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy Eur J Cancer 48 3342-3354

[5] Morrow M(2016)Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials Breast Cancer Res 18 1-268

[6] Kong X(2010)Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis Am J Roentgenol 195 260-696

[7] Moran MS(2015)Breast cancer: influence of taxanes on response assessment with dynamic contrast-enhanced MR imaging Radiology 277 687-255

[8] Zhang N(2017)The role of magnetic resonance imaging in detection of pathological complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis Clin Breast Cancer 17 245-672

[9] Haffty B(2017)Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response Radiology 283 663-35

[10] Yang Q(1950)Index for rating diagnostic tests Cancer 3 32-undefined

[1] Mieog J(2007)Neoadjuvant chemotherapy for operable breast cancer Br J Surg 94 1189-1200

[2] Van der Hage J(2015)Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy Nat Rev Clin Oncol 12 335-343

[3] Van De Velde C(2011)Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients Eur J Cancer 47 2084-2090

[4] King TA(2012)Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy Eur J Cancer 48 3342-3354

[5] Morrow M(2016)Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials Breast Cancer Res 18 1-268

[6] Kong X(2010)Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis Am J Roentgenol 195 260-696

[7] Moran MS(2015)Breast cancer: influence of taxanes on response assessment with dynamic contrast-enhanced MR imaging Radiology 277 687-255

[8] Zhang N(2017)The role of magnetic resonance imaging in detection of pathological complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis Clin Breast Cancer 17 245-672

[9] Haffty B(2017)Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response Radiology 283 663-35

[10] Yang Q(1950)Index for rating diagnostic tests Cancer 3 32-undefined